Development code · Neuroactive Steroid
LPCN 1154A
LPCN 1154A is a development code for LPCN 1154 (oral brexanolone), developed by Lipocine Inc..
- Status
- Phase 3 for Postpartum depression
- Mechanism
- GABA-A receptor PAM
- Developer
- Lipocine Inc.
Programs
Also known as
- LPCN 1154
- BRLIZIO
- brexanolone
- oral brexanolone
- allopregnanolone
- 3alpha,5alpha-tetrahydroprogesterone
- 516-54-1
- 3alpha-hydroxy-5alpha-pregnan-20-one